Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion type Assertion NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_head.
- NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion description "[Thiazolidinediones/PPAR? agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_provenance.
- NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion evidence source_evidence_literature NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_provenance.
- NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion SIO_000772 21170507 NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_provenance.
- NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion wasDerivedFrom befree-20140225 NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_provenance.
- NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_assertion wasGeneratedBy ECO_0000203 NP187399.RACAfOwRq2PKs63AWoxiMSng6Fn4KhQf1wYwFQM3UF--U130_provenance.